top of page
About Us
Complementary Team Ready to Make a Difference

We leverage decades of university research conducted by our Academic Co-founders and learnings from years of drug discovery in the field. 

Our team includes several PhDs with decades of research and professional experience ready to work to find solutions for neurodegenerative diseases.

Meet The Team
Operating Team

Luca Giani, B.S., MPP

Co-founder, CEO

Christiano Alves, PhD


Lisa Paborsky, PhD

Acting COO

Fares Nigim, MD, PhD

Co-founder, Advisor

Amy Elder, PhD

Head of Drug Discovery

Vito Vece, PhD

Synthetic Chemistry

Scientific Advisory Board / Advisors

Brad Dickerson, MD

Frontotemporal Disorders

Sabrina Paganoni, MD, PhD

ALS Clinical Sciences

Larry Steinman, MD


John Landers, PhD

ALS Genetics and Pre-clinical Sciences

Barbara Tate, PhD


John Chen, MD, PhD

Diagnostic Neuroimaging

Stephen Haggarty, PhD

Chemical Neurobiology

Michael Young, MD, MPhil

TBI, Neuroinflammation

Our Lab

We are incubated at the Pagliuca Harvard Life Lab. This state-of-the-art facility provides us with the instruments, resources and support we need to advance our experimental plan and perform assays to test our proprietary new chemical entities against neurodegenerative diseases.


Sponsors and Supporters

bottom of page